Bibliography
Strauss, K. M., Martins, L. M., Plun-Favreau, H., Marx, F. P., Kautzmann, S., Berg, D., Gasser, T., Wszolek, Z., Müller, T., Bornemann, A., Wolburg, H., Downward, J., Riess, O., Schulz, J. B., & Krüger, R. (2005). Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinsonâs disease. Human Molecular Genetics, 14(15), 2099â2111.
Authors
15
- Karsten M. Strauss (first)
- L. Miguel Martins (additional)
- Helene Plun-Favreau (additional)
- Frank P. Marx (additional)
- Sabine Kautzmann (additional)
- Daniela Berg (additional)
- Thomas Gasser (additional)
- Zbginiew Wszolek (additional)
- Thomas Müller (additional)
- Antje Bornemann (additional)
- Hartwig Wolburg (additional)
- Julian Downward (additional)
- Olaf Riess (additional)
- Jörg B. Schulz (additional)
- Rejko Krüger (additional)
References
31
Referenced
454
-
Beal, M.F. (2000) Energetics in the pathogenesis of neurodegenerative diseases. Trends Neurosci., 23, 298–304.
(
10.1016/S0166-2236(00)01584-8
) -
Schapira, A.H. (1999) Mitochondrial involvement in Parkinson's disease, Huntington's disease, hereditary spastic paraplegia and Friedreich's ataxia. Biochim. Biophys. Acta, 1410, 159–170.
(
10.1016/S0005-2728(98)00164-9
) -
Hegde, R., Srinivasula, S.M., Zhang, Z., Wassell, R., Mukattash, R., Cilenti, L., DuBois, G., Lazebnik, Y., Zervos, A.S., Fernandes-Alnemri, T. et al. (2002) Identification of Omi/HtrA2 as a mitochondrial apoptotic serine protease that disrupts inhibitor of apoptosis protein-caspase interaction. J. Biol. Chem., 277, 432–438.
(
10.1074/jbc.M109721200
) -
Martins, L.M., Iaccarino, I., Tenev, T., Gschmeissner, S., Totty, N.F., Lemoine, N.R., Savopoulos, J., Gray, C.W., Creasy, C.L., Dingwall, C. et al. (2002) The serine protease Omi/HtrA2 regulates apoptosis by binding XIAP through a reaper-like motif. J. Biol. Chem., 277, 439–444.
(
10.1074/jbc.M109784200
) -
Suzuki, Y., Imai, Y., Nakayama, H., Takahashi, K., Takio, K. and Takahashi, R. (2001) A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death. Mol. Cell, 8, 613–621.
(
10.1016/S1097-2765(01)00341-0
) -
Verhagen, A.M., Silke, J., Ekert, P.G., Pakusch, M., Kaufmann, H., Connolly, L.M., Day, C.L., Tikoo, A., Burke, R., Wrobel, C. et al. (2002) HtrA2 promotes cell death through its serine protease activity and its ability to antagonize inhibitor of apoptosis proteins. J. Biol. Chem., 277, 445–454.
(
10.1074/jbc.M109891200
) -
Martins, L.M., Turk, B.E., Cowling, V., Borg, A., Jarrell, E.T., Cantley, L.C. and Downward, J. (2003) Binding specificity and regulation of the serine protease and PDZ domains of HtrA2/Omi. J. Biol. Chem., 278, 49417–49427.
(
10.1074/jbc.M308659200
) -
Walsh, N.P., Alba, B.M., Bose, B., Gross, C.A. and Sauer, R.T. (2003) OMP peptide signals initiate the envelope-stress response by activating DegS protease via relief of inhibition mediated by its PDZ domain. Cell, 113, 61–71.
(
10.1016/S0092-8674(03)00203-4
) -
Wilken, C., Kitzing, K., Kurzbauer, R., Ehrmann, M. and Clausen, T. (2004) Crystal structure of the DegS stress sensor: how a PDZ domain recognizes misfolded protein and activates a protease. Cell, 117, 483–494.
(
10.1016/S0092-8674(04)00454-4
) -
Gray, C.W., Ward, R.V., Karran, E., Turconi, S., Rowles, A., Viglienghi, D., Southan, C., Barton, A., Fantom, K.G., West, A. et al. (2000) Characterization of human HtrA2, a novel serine protease involved in the mammalian cellular stress response. Eur. J. Biochem., 267, 5699–5710.
(
10.1046/j.1432-1327.2000.01589.x
) -
Gupta, S., Singh, R., Datta, P., Zhang, Z., Orr, C., Lu, Z., DuBois, G., Zervos, A.S., Meisler, M.H., Srinivasula, S.M. et al. (2004) The carboxy terminal tail of presenilin regulates Omi/HtrA2 protease activity. J. Biol. Chem., 279, 45844–45854.
(
10.1074/jbc.M404940200
) -
Park, H.J., Seong, Y.M., Choi, J.Y., Kang, S. and Rhim, H. (2004) Alzheimer's disease-associated amyloid beta interacts with the human serine protease HtrA2/Omi. Neurosci. Lett., 357, 63–67.
(
10.1016/j.neulet.2003.11.068
) -
Jones, J.M., Datta, P., Srinivasula, S.M., Ji, W., Gupta, S., Zhang, Z., Davies, E., Hajnoczky, G., Saunders, T.L., van Keuren, M.L. et al. (2003) Loss of Omi mitochondrial protease activity causes the neuromuscular disorder of mnd2 mutant mice. Nature, 425, 721–727.
(
10.1038/nature02052
) -
Martins, L.M., Morrison, A., Klupsch, K., Fedele, V., Moisoi, N., Teismann, P., Abuin, A., Grau, E., Geppert, M., Livi, G.P. et al. (2004) Neuroprotective role of the Reaper-related serine protease HtrA2/Omi revealed by targeted deletion in mice. Mol. Cell Biol., 24, 9848–9862.
(
10.1128/MCB.24.22.9848-9862.2004
) -
Gasser, T., Muller-Myhsok, B., Wszolek, Z.K., Oehlmann, R., Calne, D.B., Bonifati, V., Bereznai, B., Fabrizio, E., Vieregge, P. and Horstmann, R.D. (1998) A susceptibility locus for Parkinson's disease maps to chromosome 2p13. Nat. Genet., 18, 262–265.
(
10.1038/ng0398-262
) -
DeStefano, A.L., Lew, M.F., Golbe, L.I., Mark, M.H., Lazzarini, A.M., Guttman, M., Montgomery, E., Waters, C.H., Singer, C., Watts, R.L. et al. (2002) PARK3 influences age at onset in Parkinson's disease: a genome scan in the GenePD study. Am. J. Hum. Genet., 70, 1089–1095.
(
10.1086/339814
) -
Karamohamed, S., DeStefano, A.L., Wilk, J.B., Shoemaker, C.M., Golbe, L.I., Mark, M.H., Lazzarini, A.M., Suchowersky, O., Labelle, N., Guttman, M. et al. (2003) A haplotype at the PARK3 locus influences onset age for Parkinson's disease: the GenePD study. Neurology, 61, 1557–1561.
(
10.1212/01.WNL.0000095966.99430.F4
) -
Pankratz, N., Uniacke, S.K., Halter, C.A., Rudolph, A., Shults, C.W., Conneally, P.M., Foroud, T. and Nichols, W.C. (2004) Genes influencing Parkinson's disease onset: replication of PARK3 and identification of novel loci. Neurology, 62, 1616–1618.
(
10.1212/01.WNL.0000123112.51368.10
) -
Li, W., Srinivasula, S.M., Chai, J., Li, P., Wu, J.W., Zhang, Z., Alnemri, E.S. and Shi, Y. (2002) Structural insights into the pro-apoptotic function of mitochondrial serine protease HtrA2/Omi. Nat. Struct. Biol., 9, 436–441.
(
10.1038/nsb795
) - Ghadially, F.N., Yang-Steppuhn, S.E. and Lalonde, J.M. (1982) The effect of uranyl acetate on human lymphoblastoid cells (RPMI 6410) and HeLa cells. Br. J. Exp. Pathol., 63, 227–234.
-
Bancher, C., Grundke-Iqbal, I., Iqbal, K., Kim, K.S. and Wisniewski, H.M. (1989) Immunoreactivity of neuronal lipofuscin with monoclonal antibodies to the amyloid beta-protein. Neurobiol. Aging, 10, 125–132.
(
10.1016/0197-4580(89)90021-3
) -
Hicks, A.A., Petursson, H., Jonsson, T., Stefansson, H., Johannsdottir, H.S., Sainz, J., Frigge, M.L., Kong, A., Gulcher, J.R., Stefansson, K. et al. (2002) A susceptibility gene for late-onset idiopathic Parkinson disease. Ann. Neurol., 52, 549–555.
(
10.1002/ana.10324
) -
Bird, T.D., Jarvik, G.P. and Wood, N.W. (2001). Genetic association studies. Neurology, 57, 1153–1154.
(
10.1212/WNL.57.7.1153
) -
West, A.B., Zimprich, A., Lockhart, P.J., Farrer, M., Singleton, A., Holtom, B., Lincoln, S., Hofer, A., Hill, L., Muller-Myhsok, B. et al. (2001) Refinement of the PARK3 locus on chromosome 2p13 and the analysis of 14 candidate genes. Eur. J. Hum. Genet., 9, 659–666.
(
10.1038/sj.ejhg.5200698
) -
Valente, E.M., Abou-Sleiman, P.M., Caputo, V., Muqit, M.M., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A.R., Healy, D.G. et al. (2004) Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science, 304, 1158–1160.
(
10.1126/science.1096284
) -
Bonifati, V., Rizzu, P., Squitieri, F., Krieger, E., Vanacore, N., van Swieten, J.C., Brice, A., van Duijn, C.M., Oostra, B., Meco, G. et al. (2003) DJ-1 (PARK7), a novel gene for autosomal recessive, early onset parkinsonism. Neurol. Sci., 24, 159–160.
(
10.1007/s10072-003-0108-0
) -
Rathke-Hartlieb, S., Schlomann, U., Heimann, P., Meisler, M.H., Jockusch, H. and Bartsch, J.W. (2002) Progressive loss of striatal neurons causes motor dysfunction in MND2 mutant mice and is not prevented by Bcl-2. Exp. Neurol., 175, 87–97.
(
10.1006/exnr.2002.7868
) -
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y. and Shimizu, N. (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature, 392, 605–608.
(
10.1038/33416
) -
Schon, E.A. and Manfredi, G. (2003) Neuronal degeneration and mitochondrial dysfunction. J. Clin. Invest., 111, 303–312.
(
10.1172/JCI200317741
) -
Sawada, R., Lowe, J.B. and Fukuda, M. (1993) E-selectin-dependent adhesion efficiency of colonic carcinoma cells is increased by genetic manipulation of their cell surface lysosomal membrane glycoprotein-1 expression levels. J. Biol. Chem., 268, 12675–12681.
(
10.1016/S0021-9258(18)31441-8
) -
Raymond, M. and Rousset F. (1995) Genepop (version 1.2), population genetics software for exact tests and ecumenicism. J. Hered., 86, 248–249.
(
10.1093/oxfordjournals.jhered.a111573
)
Dates
Type | When |
---|---|
Created | 20 years, 2 months ago (June 16, 2005, 8:13 p.m.) |
Deposited | 2 years, 3 months ago (May 3, 2023, 8:02 a.m.) |
Indexed | 1 week, 3 days ago (Aug. 23, 2025, 1:01 a.m.) |
Issued | 20 years, 2 months ago (June 16, 2005) |
Published | 20 years, 2 months ago (June 16, 2005) |
Published Online | 20 years, 2 months ago (June 16, 2005) |
Published Print | 20 years, 1 month ago (Aug. 1, 2005) |
@article{Strauss_2005, title={Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson’s disease}, volume={14}, ISSN={0964-6906}, url={http://dx.doi.org/10.1093/hmg/ddi215}, DOI={10.1093/hmg/ddi215}, number={15}, journal={Human Molecular Genetics}, publisher={Oxford University Press (OUP)}, author={Strauss, Karsten M. and Martins, L. Miguel and Plun-Favreau, Helene and Marx, Frank P. and Kautzmann, Sabine and Berg, Daniela and Gasser, Thomas and Wszolek, Zbginiew and Müller, Thomas and Bornemann, Antje and Wolburg, Hartwig and Downward, Julian and Riess, Olaf and Schulz, Jörg B. and Krüger, Rejko}, year={2005}, month=jun, pages={2099–2111} }